BioScrip Inc (BIOS): Coliseum Capital's New Activist Target

Christopher Shackelton and Adam Gray’s Coliseum Capital initiated a new position in BioScrip Inc (NASDAQ:BIOS), according to a recent 13D filing with SEC.

Keep Reading →